Company Overview of Galleon Pharmaceuticals, Inc.
Key Executives for Galleon Pharmaceuticals, Inc.
|Joseph G. Oliveto M.B.A.||5 Relationships||Chief Executive Officer and Director||48|
|Ralph E. Christoffersen Ph.D., J.D.||64 Relationships||Managing Partner of Morgenthaler Ventures||78|
|D. Euan MacIntyre Ph.D.||No Relationships||Senior Vice President of Drug Discovery||--|
|James F. McLeod M.D.||No Relationships||Chief Medical Officer and Senior Vice President of Clinical Research and Development||--|
Galleon Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Thomas John Dietz Ph.D.||83 Relationships||Eiger BioPharmaceuticals, Inc.||52|
|Joseph G. Oliveto M.B.A.||5 Relationships||Galleon Pharmaceuticals, Inc.||48|
|Christopher K. Mirabelli Ph.D.||28 Relationships||Leap Therapeutics, Inc.||62|
|Robert F. G. Booth Ph.D.||45 Relationships||Virobay Inc.||62|
|R. Chris Christopherson Ph.D.||5 Relationships||Galleon Pharmaceuticals, Inc.||--|
Galleon Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|There is no committee data available.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.